Broad Clinical Labs

Broad Clinical Labs, formerly known as the Broad Clinical Research Sequencing Platform, was established in 2013 as a non-profit subsidiary of the Broad Institute. Through MIT and Harvard's initiatives, product development, and promotion of cutting-edge omics technologies and novel molecular testing, it accelerates the genomics community and the world’s understanding, diagnosis, and treatment of diseases. Broad Clinical Labs is a leader in whole human genome sequencing, having sequenced over 600,000 genomes to advance the understanding and diagnosis of human diseases.